Pill reduces HbA1c in Type 1
An investigational once-daily pill added to optimised insulin therapy has been shown to reduce HbA1c among adults with Type 1 diabetes during a 12-week trial
An investigational once-daily pill added to optimised insulin therapy has been shown to reduce HbA1c among adults with Type 1 diabetes during a 12-week trial
On the cover, there’s an invite for you to take a look at the online offerings happening on World Diabetes Day – 14 November (well,
A short warm-up ‘priming exercise’ could help people with diabetes exercise for longer. Sports scientists at Liverpool Hope University have discovered how the ‘VO2 kinetics’ – the time it takes for the
Research funded by Diabetes UK has revealed that going into remission of Type 2 diabetes through a low-calorie, weight management programme can restore the pancreas
For people looking to enjoy more freedom in managing their diabetes the innovative t:slim X2 insulin pump offers sleek design matched with a host of
Researchers from Denmark analysed the relationship between flu vaccinations and cardiovascular outcomes in people with diabetes. The data showed that the vaccine was associated with
A new therapy that could treat people with diabetes suffering from Covid-19 is undergoing an advanced clinical trial in the UK with the first patient
New research indicates that nearly half of hospitalised Covid-19 patients without a prior diabetes diagnosis have hyperglycaemia – which is an independent predictor of mortality
An innovative new vaccine for Type 1 diabetes is being developed, which reverses certain immune responses rather than activating the immune system. “We are trying
An overview of the movers and shakers in the world of diabetes tech with an emphasis on integration and communication. Abbott and Tandem Diabetes Care